Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study.
about
Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Low-dose capecitabine plus tra ...... gastric cancer: a pilot study.
@en
Low-dose capecitabine plus tra ...... gastric cancer: a pilot study.
@nl
type
label
Low-dose capecitabine plus tra ...... gastric cancer: a pilot study.
@en
Low-dose capecitabine plus tra ...... gastric cancer: a pilot study.
@nl
prefLabel
Low-dose capecitabine plus tra ...... gastric cancer: a pilot study.
@en
Low-dose capecitabine plus tra ...... gastric cancer: a pilot study.
@nl
P2093
P2860
P1476
Low-dose capecitabine plus tra ...... gastric cancer: a pilot study.
@en
P2093
Dong Bok Shin
Eun Kyung Cho
Hee Kyung Ahn
Hyung-Sik Kim
Inkeun Park
Jae Hoon Lee
Jinny Park
Junshik Hong
Min Young Baek
P2860
P2888
P304
P356
10.1007/S00280-015-2881-X
P577
2015-10-19T00:00:00Z